Abstract
Photodermatoses occur in males and females of all races and ages. Onset can be variable in timing and influenced by genetic and environmental factors. Photodermatoses are broadly classified as immunologically mediated, chemical- and drug-induced, photoaggravated, and genetic (defective DNA repair or chromosomal instability) diseases. Advances in the field have led to improved recognition and treatment of many photodermatoses. The purpose of this focused review is to provide an update on the diagnosis and management of a variety of photodermatoses, both common and less common, with review of recent updates in the literature pertaining to their diagnosis and management.
MeSH terms
-
Administration, Cutaneous
-
Administration, Oral
-
Dermatitis, Atopic / diagnosis
-
Dermatitis, Atopic / etiology
-
Dermatologic Agents / therapeutic use*
-
Diagnosis, Differential
-
Drug Hypersensitivity / diagnosis
-
Drug Hypersensitivity / etiology
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Light / adverse effects*
-
Lupus Erythematosus, Cutaneous / diagnosis
-
Photosensitivity Disorders / diagnosis*
-
Photosensitivity Disorders / etiology
-
Photosensitivity Disorders / pathology
-
Photosensitivity Disorders / therapy
-
Phototherapy / methods*
-
Skin / pathology
-
Skin / radiation effects
-
Sunscreening Agents / administration & dosage
-
Sunscreening Agents / adverse effects
-
Treatment Outcome
-
Urticaria / diagnosis
-
Urticaria / etiology
Substances
-
Dermatologic Agents
-
Immunosuppressive Agents
-
Sunscreening Agents